We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
(+18%)
Cap. Flow
+$342M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$163M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$137M |
| 3 |
Repligen
RGEN
|
+$104M |
| 4 |
Biogen
BIIB
|
+$104M |
| 5 |
Zoetis
ZTS
|
+$91.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 2 |
Agilent Technologies
A
|
+$137M |
| 3 |
Fidelity National Information Services
FIS
|
+$86.2M |
| 4 |
Adobe
ADBE
|
+$76.2M |
| 5 |
Keurig Dr Pepper
KDP
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.24% |
| 2 | Consumer Discretionary | 12.89% |
| 3 | Financials | 10.77% |
| 4 | Technology | 9.62% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Supernus Pharmaceuticals
SUPN
$2.73B
| $2.54M | 0.01% |
101,109
-66,028
| -40% | -$1.42M |
|
|
ABLLW
852
CALL
DELISTED
Abacus Life Warrant
ABLLW
| $2.54M | 0.01% |
+250,307
| New | +$184K |
|
|
TBCH
853
Turtle Beach Corp
TBCH
$245M
| $2.54M | 0.01% |
117,841
+99,132
| +530% | +$1.97M |
|
854
Kohl's
KSS
$2.1B
| $2.51M | 0.01% |
61,643
-125,336
| -67% | -$3.65M |
|
855
Tactile Systems Technology
TCMD
$626M
| $2.51M | 0.01% |
55,782
-185,751
| -77% | -$7.38M |
|
856
Shake Shack
SHAK
$2.48B
| $2.5M | 0.01% |
+29,447
| New | +$2.29M |
|
857
Dentsply Sirona
XRAY
$2.61B
| $2.47M | 0.01% |
+47,245
| New | +$2.33M |
|
|
CSII
858
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.46M | 0.01% |
56,304
-91,314
| -62% | -$3.44M |
|
|
SEE
859
DELISTED
Sealed Air
SEE
| $2.45M | 0.01% |
+53,534
| New | +$2.32M |
|
860
Burford Capital
BUR
$922M
| $2.44M | 0.01% |
+251,244
| New | +$2.44M |
|
861
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $2.44M | 0.01% |
+21,067
| New | +$2.39M |
|
862
iShares Silver Trust
SLV
$28.3B
| $2.44M | 0.01% |
+99,258
| New | +$2.26M |
|
863
W.R. Berkley
WRB
$28.1B
| $2.44M | 0.01% |
+82,485
| New | +$2.38M |
|
864
Helios Technologies
HLIO
$2.59B
| $2.42M | 0.01% |
45,507
-31,636
| -41% | -$1.49M |
|
865
Invesco
IVZ
$13.3B
| $2.42M | 0.01% |
+138,577
| New | +$2.13M |
|
866
National Bank Holdings
NBHC
$1.89B
| $2.42M | 0.01% |
+73,704
| New | +$2.34M |
|
|
CCX.WS
867
CALL
DELISTED
Churchill Capital Corp II Warrants, each exercisable for one share of Class A common stock at an exe
CCX.WS
| $2.42M | 0.01% |
+233,332
| New | +$345K |
|
868
Automatic Data Processing
ADP
$102B
| $2.41M | 0.01% |
+13,693
| New | +$2.25M |
|
869
Tenable Holdings
TENB
$3.58B
| $2.41M | 0.01% |
46,095
-163,434
| -78% | -$6.47M |
|
870
Boyd Gaming
BYD
$6.64B
| $2.4M | 0.01% |
+55,879
| New | +$2.05M |
|
871
CrowdStrike
CRWD
$183B
| $2.39M | 0.01% |
+45,164
| New | +$1.76M |
|
872
Griffon
GFF
$4.28B
| $2.39M | 0.01% |
117,198
-215,207
| -65% | -$4.63M |
|
873
Advanced Micro Devices
AMD
$807B
| $2.38M | 0.01% |
25,902
+380
| +1% | +$32.8K |
|
|
NLSN
874
DELISTED
Nielsen Holdings plc
NLSN
| $2.37M | 0.01% |
+113,437
| New | +$1.84M |
|
|
VIVO
875
DELISTED
Meridian Bioscience Inc
VIVO
| $2.36M | 0.01% |
126,430
+37,483
| +42% | +$700K |
|
Similar funds
Marshall Wace's Q4 2020 Portfolio in Review
As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
- Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
- Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
- Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
- Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
- Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.
Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.